OBJECTIVE To determine the pharmacokinetics and adverse effects of maropitant citrate after IV and SC administration to New Zealand White rabbits (Oryctolagus cuniculus). ANIMALS 11 sexually intact (3 males and 8 females) adult rabbits. PROCEDURES Each rabbit received maropitant citrate (1 mg/kg) IV or SC. Blood samples were collected at 9 (SC) or 10 (IV) time points over 48 hours. After a 2-week washout period, rabbits received maropitant by the alternate administration route. Pharmacokinetic parameters were calculated. Body weight, food and water consumption, injection site, mentation, and urine and fecal output were monitored. RESULTS Mean ± SD maximum concentration after SC administration was 14.4 ± 10.9 ng/mL and was detected at 1.25 ± 0.89 hours. Terminal half-life after IV and SC administration was 10.4 ± 1.6 hours and 13.1 ± 2.44 hours, respectively. Bioavailability after SC administration was 58.9 ± 13.3%. Plasma concentration at 24 hours was 2.87 ± 1.69 ng/mL after IV administration and 3.4 ± 1.2 ng/mL after SC administration. Four rabbits developed local dermal reactions at the injection site after SC injection. Increased fecal production was detected on the day of treatment and 1 day after treatment. CONCLUSIONS AND CLINICAL RELEVANCE Plasma concentrations of rabbits 24 hours after SC and IV administration of maropitant citrate (1 mg/kg) were similar to those of dogs at 24 hours. Reactions at the SC injection site were the most common adverse effect detected. Increased fecal output may suggest an effect on gastrointestinal motility. Additional pharmacodynamic and multidose studies are needed.
OBJECTIVE To document clinicopathologic findings in domestic rabbits with liver lobe torsion and identify prognostic factors. ANIMALS 82 rabbits. PROCEDURE Medical records of 4 institutions were reviewed to identify rabbits with an antemortem diagnosis of liver lobe torsion that were examined between 2010 and 2020. RESULTS The prevalence of liver lobe torsion was 0.7% (82/11,402). In all 82 rabbits, the diagnosis was made by means of abdominal ultrasonography. Fifty (60.1%) rabbits underwent liver lobectomy, 23 (28%) received medical treatment alone, and 9 (10.9%) were euthanized or died on presentation. Overall, 32 (39%) rabbits died within 7 days of initial presentation and 50 (61%) survived. Seven-day survival rate did not differ significantly between medical treatment alone and surgical treatment. However, median survival time following medical treatment (530 days) was shorter than that following surgical treatment (1,452 days). Six of 14 rabbits had evidence of systemic inflammatory disease on necropsy. Rabbits with right liver lobe torsion were less likely to survive for 7 days than were those with caudate torsions (P = 0.046; OR, 3.27; 95% CI, 1.04 to 11.3). Rabbits with moderate to severe anemia were less likely to survive for 7 days than were rabbits that were not anemic or had mild anemia (P = 0.006; OR, 4.41; 95% CI, 1.55 to 12.51). Other factors associated with a decreased 7-day survival rate were high heart rate at admission (P = 0.013) and additional days without defecation after admission (P < 0.001). Use of tramadol was associated with an increased survival rate (P = 0.018). CLINICAL RELEVANCE The prognosis for rabbits with liver lobe torsions was more guarded than previously described. Rabbits that underwent liver lobectomy had a longer median survival time than did rabbits that only received medical treatment.
P. aeruginosa is the predominant bacterial species associated with bacterial conjunctivitis in chinchillas. With the exception of duration of clinical signs, information on the anamnesis or physical examination findings cannot aid in distinguishing conjunctivitis caused by P. aeruginosa or other Gram-negative bacteria from the ones caused by Gram-positive bacteria. Gentamicin- or polymyxin B-containing antibiotic formulations are recommended for empirical topical therapy.
OBJECTIVE To evaluate the effects of restraint time and thermometer insertion depth on rectal temperature measurements in chinchillas and determine the extent of agreement between temperatures measured with 2 tympanic and a rectal thermometer. DESIGN Prospective method comparison study. ANIMALS 47 healthy chinchillas. PROCEDURES Effects of 1- and 2-cm rectal thermometer insertion depths and the effect of manual restraint for up to 5 minutes were evaluated. Near simultaneous temperature measurements were obtained with a human tympanic, a veterinary tympanic, and a rectal thermometer by 2 observers. Duplicate temperature measurements were obtained for each method, and the sequence of measurements was randomized for each animal. RESULTS Rectal temperature readings obtained at a depth of 2 cm were significantly higher (mean ± SD, 1.14 ± 0.77°C [2.05° ± 1.39°F]) than those obtained at 1 cm. After 3 minutes, manual restraint had a significant effect on rectal temperature. The reference interval for rectal temperature in chinchillas with a 2-cm thermometer insertion depth was calculated as 34.9° to 37.9°C (94.8° to 100.2°F). Both tympanic infrared thermometers had significant systematic bias (0.42 ± 0.12°C [0.76° ± 0.22°F]) and proportional bias (0.88 ± 0.14°C [1.58° ± 0.25°F]). The coefficients of reliability for the rectal thermometer, the human tympanic thermometer, and the veterinary tympanic thermometer were 0.86, 0.85, and 0.69, respectively. CONCLUSIONS AND CLINICAL RELEVANCE Rectal thermometer insertion depth and duration of manual restraint had a significant effect on rectal temperature measurements in chinchillas. Because of significant systematic and proportional bias, tympanic thermometry was not considered a suitable replacement for rectal thermometry in chinchillas.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.